Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,989
Views
3
CrossRef citations to date
0
Altmetric
Coronavirus – Review

Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis

Patrick D. M. C. Katotoa Office of the President and CEO, South African Medical Research Council, Cape Town, South Africa;b Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa;c Centre for Tropical Diseases and Global Health, Department of Medicine, Catholic University of Bukavu, Bukavu, DR CongoCorrespondence[email protected]
View further author information
,
Amanda S. Brandd Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaView further author information
,
Liliane N. Byamungue Department of Pediatric, Faculty of Medicine and Health Sciences, University of KwaZulu-Natal, Durban, South AfricaView further author information
,
Jacques L. Tamuzib Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaView further author information
,
Tamirirashe C. Mahwireb Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaView further author information
,
Marcel K. Kitengeb Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaView further author information
,
Charles S. Wiysongef Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa;g HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South AfricaView further author information
&
Glenda Graya Office of the President and CEO, South African Medical Research Council, Cape Town, South AfricaView further author information
 show all
Article: 2144039 | Received 14 Aug 2022, Accepted 11 Oct 2022, Published online: 11 Nov 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Patrick DMC. Katoto, Jacques L. Tamuzi, Amanda S. Brand, Diana M. Marangu, Liliane N. Byamungu, Charles S. Wiysonge & Glenda Gray. (2023) Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 19:1.
Read now
Pio Lopez, Lulu Bravo, Erik Buntinx, Charissa Borja-Tabora, Hector Velasquez, Edith Johana Rodriquez, Camilo A. Rodriguez, Josefina Carlos, May Emmeline B. Montellano, Edison R. Alberto, Milagros Salvani-Bautista, Yung Huang, Branda Hu, Ping Li, Htay Htay Han, Carmen Baccarini & Igor Smolenov. (2023) Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents. Human Vaccines & Immunotherapeutics 19:1.
Read now

Articles from other publishers (1)

Helena C. Maltezou, Sophia Hatziantoniou, Kalliopi Theodoridou, Konstantinos Vasileiou, Cleo Anastassopoulou & Athanasios Tsakris. (2023) Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance. Vaccine 41:14, pages 2382-2386.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.